Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222, Japan (Received for publication April 17, 1995) DNAamplification by polymerase chain reaction (PCR) should be inhibited if the target for amplification region in the template DNAis nicked or cut. Based on this premise, we established a sensitive and differential assay using PCR to detect antibiotics that act on DNA.After template ADNA(lOpg) was incubated with antibiotics (10-20ng) at 37°C for 30minutes in a 5^1 reaction volume, a PCRassay (10 /xl reaction volume; 25 -30 cycles) was performed under the conditions we modified, resulting in amplification of a 500 bp fragment of ADNAwhich was monitored by agarose gel electrophoresis.
Among the several antibiotics examined, the anthracyclines, bleomycin, D-cycloserine and mitomycin C clearly inhibited the PCRamplification reaction, whereas actinomycin D and ofloxacin did not. Preincubation of template DNAin the presence of Fe+ + was necessary for bleomycin and cycloserine to exhibit marked inhibition ofPCR. Mitomycin C exhibited the inhibition in the presence of DTTand Cu+. By contrast, non-DNA-acting antibiotics (200ng) such as aminoglycosides, /Mactams, and macrolides showed no inhibition. The PCR-amplified fragment from ADNAwas not degraded by incubation with the antibiotics (20ng) that inhibited PCR. Furthermore, ethylacetate extracts of the cultured broths of actinomycetes proved to be suitable as samples for this PCRinhibition assay.
Polymerase chain reaction (PCR)1'2* has revolutionized gene technology and was developed for the. /w vitro amplification of specifically targeted DNAsequences. In principle, it is possible to amplify any specific region with knownnucleotide sequencesfromevena single molecule of DNA. Basic requirements for PCRinclude a template DNA, two oligonucleotide primers corresponding to both ends of the target region, and a DNApolymerase such as Taq polymerase, respectively. However, if any one of these factors is damaged, the amplification of DNAwill be inhibited. In this context, there are a variety of antibiotics that have been known to cause DNA strand scission. If such antibiotics make a nick or cut in the target for amplification of the template DNA, primer extension by DNApolymerase should stop at the nicked or cut site, resulting in total or strong inhibition of amplification of the target region. In addition, since an extremely low level of the template DNAis sufficient for DNAamplification by PCR, it seemed very likely that the level of antibiotics necessary for inhibition of PCR should be low.
Based on this insight, we attempted to establish a sensitive and differential PCR inhibition assay for 1267 antibiotics that are capable of nicking or cutting DNA strands. In practice, we did not use any specific template and primers, only the ADNAand primers provided as positive control materials as part of a commercial PCR kit, materials which are usually sitting in a freezer without any other specific use.
Materials and Methods
Polymerase Chain Reaction (PCR) GeneAmpPCR Kit (Perkin Elmer Cetus), containing ADNA template, primers #1 and #2, dNTPs (dATP,  dCTP, dGTP and dTTP) and Taq polymerase, was purchased from Takara Shuzo, Japan. The positive control conditions described for the amplification of a 500 bp fragment from ADNAwere used as the standard After PCRwas completed, the amplification of a 500 bp DNAfragment spanning nucleotide Nos. 7131~7160 of ADNAwas monitored by subjecting 10jA of the reaction mixture to agarose gel electrophoresis using 0.8% agarose ME(Marine Colloids, Div.) in TAE buffer containing 0.5 /ig/ml of ethidium bromide3).
For examination of the effect of antibiotics or ethylacetate extracts of cultured broths, these materials were incubated at 37°C for 30minutes with the template DNAin a 5/A volume and then 5fil of 2xPCR buffer containing double strength of primers, dNTPs and Taq polymerase was added in order to start PCRunder the modified conditions described in Results. supernatants wereevaporated in vacuo to dryness and then resuspended with MilliQ water a volume equal to the supernatants. These solutions were diluted 10 fold for use in the PCR assay.
Results

Modification of PCR Conditions To establish a PCR inhibition
assay with a high sensitivity in a small reaction volume, the standard PCR conditions specified by the supplier (Table 1) were NOV. 1995 modified. First, we examined the effect of reaction volume on PCR using 10pg//il of 2DNAas the template under the following incubation condition: 95°C/1 minute-> 45°C/1 minute->72°C/1 minute. As shown in Fig. 1 Then, PCRusing reduced concentrations of the template DNA(l pg/7/1) and dNTPs (0.4mM) was attempted in 10 /A reaction volume. DNAamplification was clearly observed under these modified conditions ( Fig. 1-B) .
Consequently, the modified conditions shown in Table  1 Effect of incubation time was also examined ( Table  2 ). It turned out that DNAamplification was clearly observed even under the condition of 95°C/20 seconds-åº 45°C/10 seconds->72°C/10 seconds, requiring a markedly reduced total incubation time (19minutes).
Although this condition saves time for completion of 25 cycles of PCR, the standard incubation condition requiring 77 minutes was used for examining the effect of antibiotics on PCRin the following experiments.
Effect of Antibiotics on PCR Based on the above results, we designed the following procedure for the PCRinhibition assay. Template DNA (10pg) was preincubated at 37°C for 30minutes in the 4)Concentration was 0. 1 and 0.01ng/|j,l for standard and modified conditions, respectively. single strand scission of DNAin the presence of ferrous ion and molecular oxygen5'6) and the latter to inhibit protein synthesis7).
In comparison with the positive control (without antibiotic), bleomycin (lO ng/assay or higher in the presence of 1.3 /zm FeSO4) clearly inhibited amplification of a 500 bp fragment from ADNA template that was preincubated with the antibiotic. Substitution of Streptomyces DNAand kan gene primers for ADNA and primers #1 and #2 did not bring any change in the results (data not shown). However, no substantial inhibition was observed without preincubation. On the other hand, kanamycin did not inhibit the amplification even at 10-fold higher concentration (200 ng/assay) than bleomycin, regardless of preincubation conditions. PCRresults obtained with antibiotics that have been known to interact with DNAare summarized in Table   3 . Clear inhibition of the DNA amplification was observed with anthracyclines (pirarubicin, and to a lesser extent, daunomycin, doxorubicin and epirubicin), bleomycin, peplomycin, cycloserine and mitomycin C when the template /IDNAwas preincubated with them.
In addition, acriflavine, ethidium bromide which have been known to intercalate DNA8) showed a similar inhibition.
The PCR inhibition by bleomycin (Fig. 2 ADNAfragment (50 ng) amplified by PCR were incubated with antibiotics (20ng) at 37°C for 30minutes in 10jA. RNAsynthesis) and ofloxacin (one of quinolone antibiotics that inhibit DNAgyrase12)) at least under the concentrations tested. Fig. 3 shows the effect of preincubation time of the template with antibiotics on DNAamplification. Subsequently, it turned out that the preincubation was effective for bleomycin to exhibit clear PCR inhibition. However, there was no significant difference in PCR inhibition by epirubicin between the result with preincubation and the one without preincubation. Similar results were obtained with DNA-intercalating agents such as anthracyclines, acriflavine and ethidium bromide as seen in Table 3 . Table 4 shows the effect of a variety of antibiotics that cause no damage to DNAon the PCRassay. It turned out that none of them inhibited the DNAamplification by PCR even when the template DNAwas exposed to 10-fold higher quantity (200 ng) of the antibiotics. DNAdegradation test was also carried out. The 500 bp ADNAPCR fragment (estimated at 50-100ng) was incubated at 37°C for 30 minutes in 5 [A reaction volume with 20ng of the antibiotics that inhibited PCR. However, no degradation was observed (Fig. 4) . DNA degradation was observed when the same quantity of XDNA was exposed to 300fig of bleomycin or adriamycin (doxorubicin).
Effect of Ethylacetate Extracts of
Cultured Broths on PCR The PCRinhibition assay established as above was applied for screening the cultured broths of actinomycetes for active substances. Two [A of centrifugedsupernatants (with or without heating at 70°C for 10 minutes) or ethylacetate extracts of about 250 cultured Mitomycin C also inhibited PCR when preincubated with the template in the presence of sodium hydrosulfite and Cu++that are required for the single strand scission by the antibiotic of DNA9). Although we did not examined in this study, diyne-ene-containing antitumor antibiotics12) such as neocarzinostatin14), macromomycin15), and esperamicins16) including FR-90040517) (=esperamicin Alb) that are known to have 1,000 fold higher antitumor activity than doxorubicin (adriamycin) should also inhibit PCR. Clear PCR inhibition was detected by the bleomycin group and cycloserine with addition of a low level of FeSO4 and by anthracyclines without the addition of ferrous ion, although the reaction mixture of PCR inhibition assay was not supplementedwith any reducing agent. This is due to the fact that the level of the template DNAwas extremely low (1 ng/ml) compared to those levels (3~250 /ig/ml) employed in the DNAdegradation tests reported5'18'19).
Preincubation is not necessary for DNA-intercalaters (anthracyclines, acriflavine and ethidium bromide) but is required for bleomycin to show PCR inhibitory activity.
Since bleomycin does not require ferric ion (Fe+++) but ferrous ion (Fe++) for its DNA strand scission activity, the failure in PCR inhibition by bleomycin without the preincubation might be due to a rapid conversion ofFe++ to Fe+++ by exposing to the elevated high temperature (95°C, 2 minutes) upon initial heating for DNAdenaturation in PCR.
Aclarubicin showed no significant activity in contrast with the other anthracylines. This will be due to its weak DNAbreaking activity as reported in comparison with doxorubicin (adriamycin)1 8 
